Cargando…

Editorial: Contemporary Perspective on 5-HT(2C) Receptor Function and Its Pharmacological Targeting

Detalles Bibliográficos
Autores principales:	De Deurwaerdère, Philippe, Chagraoui, Abdeslam, Cunningham, Kathryn A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724505/ https://www.ncbi.nlm.nih.gov/pubmed/33324228 http://dx.doi.org/10.3389/fphar.2020.606414

Ejemplares similares

Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases
por: De Deurwaerdère, Philippe, et al.
Publicado: (2021)

Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
por: Chagraoui, Abdeslam, et al.
Publicado: (2022)

Editorial: Insights on neuroinflammatory response by microglia-targeted pharmacology
por: Raber, Jacob, et al.
Publicado: (2023)

Editorial: New GPCR targets and modulators to treat CNS disorders
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022)

Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
por: Di Giovanni, Giuseppe, et al.
Publicado: (2020)

A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT(2C) Receptors in Rats: Implication of the Subthalamic Nucleus
por: Lagière, Mélanie, et al.
Publicado: (2020)

Effect of the 5-HT(2C) Receptor Agonist WAY-163909 on Serotonin and Dopamine Metabolism across the Rat Brain: A Quantitative and Qualitative Neurochemical Study
por: Whitestone, Sara, et al.
Publicado: (2019)

The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties
por: Beattie, David T., et al.
Publicado: (2011)

Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
por: Miguelez, Cristina, et al.
Publicado: (2020)

The role of the serotonin receptor subtypes 5-HT(1A) and 5-HT(7) and its interaction in emotional learning and memory
por: Stiedl, Oliver, et al.
Publicado: (2015)

Conservation of 5-HT(1A) receptor-mediated autoinhibition of serotonin (5-HT) neurons in mice with altered 5-HT homeostasis
por: Araragi, Naozumi, et al.
Publicado: (2013)

Editorial: 5-HT(2A/2B/2C) Receptors, Memory, and Neuropsychiatric Disorders
por: Gasbarri, Antonella, et al.
Publicado: (2016)

Serotonin 5-HT(2C) Receptor Activation Suppresses Binge Intake and the Reinforcing and Motivational Properties of High-Fat Food
por: Price, Amanda E., et al.
Publicado: (2018)

Kampo Medicine: Evaluation of the Pharmacological Activity of 121 Herbal Drugs on GABA(A) and 5-HT(3A) Receptors
por: Hoffmann, Katrin M., et al.
Publicado: (2016)

The 5-HT7 receptor as a potential target for treating drug and alcohol abuse
por: Hauser, Sheketha R., et al.
Publicado: (2015)

In Vivo and In Vitro Analyses of Novel Peptidomimetic Disruptors for the Serotonin 5-HT(2C) Receptor Interaction With Phosphatase and Tensin Homolog
por: Soto, Claudia A., et al.
Publicado: (2019)

Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives
por: Roseman, Leor, et al.
Publicado: (2022)

Editorial: The Pharmacology of Kratom and Its Alkaloids
por: Grundmann, Oliver, et al.
Publicado: (2022)

Anti-PTSD Effects of Hypidone Hydrochloride (YL-0919): A Novel Combined Selective 5-HT Reuptake Inhibitor/5-HT(1A) Receptor Partial Agonist/5-HT(6) Receptor Full Agonist
por: Liu, Wen-Gang, et al.
Publicado: (2021)

Chronic Administration of Fipronil Heterogeneously Alters the Neurochemistry of Monoaminergic Systems in the Rat Brain
por: Bharatiya, Rahul, et al.
Publicado: (2020)

5-HT6 receptor agonism facilitates emotional learning
por: Pereira, Marcela, et al.
Publicado: (2015)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021)

Neuronal localization of the 5-HT(2) receptor family in the amygdaloid complex
por: Bombardi, Cristiano
Publicado: (2014)

Hippocampal 5-HT(1A) Receptor and Spatial Learning and Memory
por: Glikmann-Johnston, Yifat, et al.
Publicado: (2015)

The role of serotonin 5-HT(2A) receptors in memory and cognition
por: Zhang, Gongliang, et al.
Publicado: (2015)

Capsaicin Is a Negative Allosteric Modulator of the 5-HT(3) Receptor
por: Nebrisi, Eslam El, et al.
Publicado: (2020)

L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
por: Chagraoui, Abdeslam, et al.
Publicado: (2019)

Editorial: Computational and Experimental Approaches in Multi-target Pharmacology
por: Anastasio, Thomas J.
Publicado: (2017)

Binding and functional structure-activity similarities of 4-substituted 2,5-dimethoxyphenyl isopropylamine analogues at 5-HT(2A) and 5-HT(2B) serotonin receptors
por: Hemanth, Prithvi, et al.
Publicado: (2023)

Endogenous 5-HT outflow from chicken aorta by 5-HT uptake inhibitors and amphetamine derivatives
por: DELGERMURUN, Dugar, et al.
Publicado: (2015)

MDMA-Induced Dissociative State not Mediated by the 5-HT(2A) Receptor
por: Puxty, Drew J., et al.
Publicado: (2017)

Chronic Fluoxetine Impairs the Effects of 5-HT(1A) and 5-HT(2C) Receptors Activation in the PAG and Amygdala on Antinociception Induced by Aversive Situation in Mice
por: Baptista-de-Souza, Daniela, et al.
Publicado: (2020)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Novel pharmacological approaches targeting mitochondrial dysfunction in diseases
por: Uddin, Md. Jamal, et al.
Publicado: (2022)

Editorial: New immunotherapeutic and pharmacological targets and strategies in haematological malignancies
por: Williams, Mark Thomas Shaw, et al.
Publicado: (2023)

Editorial: Purinergic Pharmacology
por: Ciruela, Francisco, et al.
Publicado: (2019)

Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics
por: Chandrasekaran, Balakumar, et al.
Publicado: (2023)

Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective
por: Šíma, Martin, et al.
Publicado: (2023)

Editorial: The inaugural Monash international health science and technology conference: pharmacology perspectives
por: Khaw, Kooi Yeong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_akvbnb2icna0qs607r3io9vmqd